Megna Michael R

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$816,660.07

Insider Activity of Megna Michael R

According to the SEC Form 4 filings, Megna Michael R, being in a position of

  1. CHIEF ACCOUNTING OFFICER at Kiniksa Pharmaceuticals, Ltd.,
    оver the last 12 months, has bought 0 shares, and sold 40771 share for $816,660,
    over all time since 2023-12-19, has bought 0 shares, and sold 40771 share for $816,660.

The largest sale of all time was on 2024-01-02 and amounted to 16670 shares of Kiniksa Pharmaceuticals, Ltd. for $319,564.

Biography of Megna Michael R

No biography is available at this moment.

2024-03-01SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
9,659
0.0136%
$21.45$207,186-8.07%
2024-02-28SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
5,126
0.0078%
$21.79$111,696-1.79%
2024-01-02SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
16,670
0.0245%
$19.17$319,564+6.63%
2023-12-19SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF ACCOUNTING OFFICER
9,316
0.0133%
$19.13$178,215+3.49%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.